Investor Relations
Investing in the latest bone marrow / hematopoietic stem cell transplantation technology
Investor Alert
Sign up for Email Alerts
Other videos

Hemogenyx CDX Antibodies overview

Hemogenyx Hu PHEC overview

A new era for the treatment of blood diseases
Our aim is to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy.